DNB
82
4
FTI
81
5
TRIP
47
3
LLY
37
-3
KEY
46
3
MHK
49
4
YUM
47
3
AIV
72
2
EQIX
64
2
LRCX
43
-2
NWL
53
3
INTC
33
-2
ADBE
49
3
CPB
30
6
XYL
49
4
GS
75
2
NSC
60
3
WBA
48
4
M
37
12
PLD
56
8
DNB
82
4
FTI
81
5
TRIP
47
3
LLY
37
-3
KEY
46
3
MHK
49
4
YUM
47
3
AIV
72
2
EQIX
64
2
LRCX
43
-2
NWL
53
3
INTC
33
-2
ADBE
49
3
CPB
30
6
XYL
49
4
GS
75
2
NSC
60
3
WBA
48
4
M
37
12
PLD
56
8
Financhill
Back

NeuroOne Medical Technologies 10K Form

Sell
28

NMTC
NeuroOne Medical Technologies

Last Price:
0.70
Seasonality Move:
117.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-12 10K NMTC/NeuroOne Medical Technologies Annual
2021-01-28 10K NMTC/NeuroOne Medical Technologies Annual
2020-12-09 10K NMTC/NeuroOne Medical Technologies Annual
2020-08-13 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-05-14 10Q NMTC/NeuroOne Medical Technologies Quarterly
2020-02-14 10Q NMTC/NeuroOne Medical Technologies Quarterly

Receive NMTC News And Ratings

See the #1 stock for the next 7 days that we like better than NMTC

NMTC Financial Statistics

Sales & Book Value

Annual Sales: $1.95M
Cash Flow: $-2.38M
Price / Cash Flow: 0
Annual Sales: $0.11
Price / Book: 6.97

Profitability

EPS (TTM): -0.48000
Net Income (TTM): $-12.1M
Gross Margin: $456.52K
Return on Equity: -282.05%
Return on Assets: -201.81%

NeuroOne Medical Technologies Earnings Forecast

Key NeuroOne Medical Technologies Financial Ratios

  • The Gross Profit Margin over the past 8 years for NMTC is 23.38%.
  • The Selling, General & Administrative Expenses for NMTC have been equal to 354.75% of Gross Profit Margin.
  • The Research & Development expenses have been 355.49% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of NMTC is -607.42% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 5 years.

NeuroOne Medical Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: NMTC
Website: n1mtc.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.42
Quick Ratio: 1.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NMTC Technical Analysis vs Fundamental Analysis

Sell
28
NeuroOne Medical Technologies (NMTC) is a Sell

Is NeuroOne Medical Technologies a Buy or a Sell?